The clinic emphasizes science-based strategies with realistic goals, continuous support, and clinical accountability
Prior studies have demonstrated superior weight-loss efficacy with higher doses of both agents, but direct comparisons have been limited and often restricted to specific dose combinations or populations without diabetes
Ozempic, approved for type 2 diabetes, and Wegovy, for obesity, both powered by semaglutide, generated about $7.9 billion in just-reported second-quarter sales
By acting on the GLP-1 receptors, semaglutide amplifies these beneficial effects, leading to improved insulin sensitivity and glucose uptake by the cells
Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines